Survival Patterns in Advanced Hodgkin's Disease
Author Information
Author(s): A.M. Oza, T.S. Ganesan, M. Dorreen, P.W.M. Johnson, J. Waxman, W. Gregory, J. Lim, J. Wright, L. Dadiotis, V. Barbounis, A.G. Stansfeld, A.Z.S. Rohatiner, J.S. Malpas, P.F.M. Wrigley, T.A. Lister
Primary Institution: ICRF Department of Medical Oncology, St Bartholomew's Hospital, London
Hypothesis
What are the long-term survival patterns and remission rates in patients with advanced Hodgkin's disease treated with MVPP chemotherapy?
Conclusion
The study found that achieving complete remission significantly improves long-term survival in patients with advanced Hodgkin's disease.
Supporting Evidence
- Complete remission was achieved in 59% of patients after six cycles of chemotherapy.
- Patients with higher serum albumin levels had better remission rates.
- The median survival from presentation was 14 years for patients who achieved remission.
Takeaway
This study looked at how well people with advanced Hodgkin's disease did over a long time after getting treatment. Most people who got better stayed that way for many years.
Methodology
The study analyzed 164 adults with advanced Hodgkin's disease who received MVPP chemotherapy and followed their outcomes over a median of 14 years.
Potential Biases
There may be biases related to the treatment protocols and patient selection over the 20-year study period.
Limitations
The study is limited by its retrospective nature and the potential for selection bias in the patient population.
Participant Demographics
The cohort consisted of 122 males and 42 females, with ages ranging from 13 to 79 years, and a median age of 36.
Statistical Information
P-Value
0.0002
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website